Correlation Between Neuropace and Sight Sciences

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Neuropace and Sight Sciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuropace and Sight Sciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neuropace and Sight Sciences, you can compare the effects of market volatilities on Neuropace and Sight Sciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuropace with a short position of Sight Sciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuropace and Sight Sciences.

Diversification Opportunities for Neuropace and Sight Sciences

-0.54
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Neuropace and Sight is -0.54. Overlapping area represents the amount of risk that can be diversified away by holding Neuropace and Sight Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sight Sciences and Neuropace is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuropace are associated (or correlated) with Sight Sciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sight Sciences has no effect on the direction of Neuropace i.e., Neuropace and Sight Sciences go up and down completely randomly.

Pair Corralation between Neuropace and Sight Sciences

Given the investment horizon of 90 days Neuropace is expected to generate 1.33 times more return on investment than Sight Sciences. However, Neuropace is 1.33 times more volatile than Sight Sciences. It trades about 0.1 of its potential returns per unit of risk. Sight Sciences is currently generating about -0.19 per unit of risk. If you would invest  792.00  in Neuropace on August 30, 2024 and sell it today you would earn a total of  233.00  from holding Neuropace or generate 29.42% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Neuropace  vs.  Sight Sciences

 Performance 
       Timeline  
Neuropace 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.
Sight Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Sight Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Neuropace and Sight Sciences Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Neuropace and Sight Sciences

The main advantage of trading using opposite Neuropace and Sight Sciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuropace position performs unexpectedly, Sight Sciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sight Sciences will offset losses from the drop in Sight Sciences' long position.
The idea behind Neuropace and Sight Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Equity Valuation
Check real value of public entities based on technical and fundamental data
Fundamental Analysis
View fundamental data based on most recent published financial statements
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges